
ASTH Valuation
Astrana Health Inc
- Overview
- Forecast
- Valuation
- Earnings
ASTH Relative Valuation
ASTH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ASTH is overvalued; if below, it's undervalued.
Historical Valuation
Astrana Health Inc (ASTH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 12.21 is considered Undervalued compared with the five-year average of 36.94. The fair price of Astrana Health Inc (ASTH) is between 32.19 to 90.25 according to relative valuation methord. Compared to the current price of 22.81 USD , Astrana Health Inc is Undervalued By 29.14%.
Relative Value
Fair Zone
32.19-90.25
Current Price:22.81
29.14%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.48
P/B
Median3y
2.88
Median5y
3.76
4.64
FCF Yield
Median3y
2.81
Median5y
3.28
Competitors Valuation Multiple
The average P/S ratio for ASTH's competitors is 1.23, providing a benchmark for relative valuation. Astrana Health Inc Corp (ASTH) exhibits a P/S ratio of 0.32, which is -74.16% above the industry average. Given its robust revenue growth of 53.43%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

DBRG
DigitalBridge Group Inc
11.090
USD
-1.16%

LION
Lionsgate Studios Corp
6.540
USD
+0.62%

VITL
Vital Farms Inc
36.380
USD
-0.11%

TGS
Transportadora de Gas del Sur SA
27.680
USD
+2.59%

OMCL
Omnicell Inc
28.270
USD
+0.50%

COCO
Vita Coco Company Inc
37.920
USD
+0.40%

FL
Foot Locker Inc
25.490
USD
+1.27%

BEAM
Beam Therapeutics Inc
21.720
USD
+3.68%

HLMN
Hillman Solutions Corp
8.070
USD
-0.12%

TALO
Talos Energy Inc
8.790
USD
-1.01%
FAQ

Is Astrana Health Inc (ASTH) currently overvalued or undervalued?
Astrana Health Inc (ASTH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 12.21 is considered Undervalued compared with the five-year average of 36.94. The fair price of Astrana Health Inc (ASTH) is between 32.19 to 90.25 according to relative valuation methord. Compared to the current price of 22.81 USD , Astrana Health Inc is Undervalued By 29.14% .

What is Astrana Health Inc (ASTH) fair value?

How does ASTH's valuation metrics compare to the industry average?

What is the current P/B ratio for Astrana Health Inc (ASTH) as of Jul 25 2025?

What is the current FCF Yield for Astrana Health Inc (ASTH) as of Jul 25 2025?

What is the current Forward P/E ratio for Astrana Health Inc (ASTH) as of Jul 25 2025?
